Companies / Germany
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Merck KGaA To Build Biopharmaceutical Plant
August 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Confirming its commitment to the growing biotechnology sector, German firm Merck KGaA has decided to construct a biopharmaceutical production plant at its headquarters in Darmstadt, Germany. At an estimated cost of EUR190mn (US$244mn), the facility represents the second-largest single investment ever made by the company. Approximately 190 highly skilled employees will be recruited to operate the plant and construction is expected to commence in